The study published in Science helps us understand the role of this little-studied type of vegetation in climate change. One percent of the tallest trees store more than half of the carbon in tropical forest ecosystems.
In systems inspired by neural networks and synapses, an oxide-based structure combines processing and memory into a single component, with the potential to reduce energy consumption and increase efficiency.
The initiative, estimated to cost BRL 30 million, brings together FAPESP, the University of São Paulo, the State Department for the Environment, and the productive sector.
The fungus is one of the leading causes of hospital-acquired infections.
An analysis of 60,000 records of flooding, waterlogging, flash floods, landslides, storms, and droughts reveals regional impacts in Brazil and may inform public policy.
An international team of researchers has proposed a non-pharmacological intervention based on a physiological signal that precedes the neuronal storm of an epileptic seizure.
A study that tracked 1,500 people over a decade found that infrastructure within 500 meters of one’s home is crucial for adopting active transportation. However, the uneven distribution of the bike lane network remains a challenge in the metropolis.
Findings from a study that monitored a group in Carlos Botelho State Park in São Paulo, Brazil, help shed light on the habitat use of this vulnerable species.
The CABRA project, which received BRL 10 million in funding, will study the synergies between ethanol plants and basaltic formations in Brazil’s Southeast region.
The FAPESP-backed health tech company is now headquartered in Switzerland and is developing a platform to produce tissues in a lab. The goal is to obtain clinical approval for transplantation within ten years.
Researchers analyzed samples of sediment preserved in stalagmites to reconstruct the region’s climatic history. The 20th century saw one of the highest frequencies of extreme events in the last 7,500 years.
The FAPESP-backed health tech company is now headquartered in Switzerland and is developing a platform to produce tissues in a lab. The goal is to obtain clinical approval for transplantation within ten years.